Synonyms: Example 1 [US20090137530] | MT-1303 | MT1303
Compound class:
Synthetic organic
Comment: Amiselimod (MT-1303) is claimed in patent US20090137530 (Compound 1-3 is the hydrochloride used experimentally) as a potential immunomodulatory agent [1]. It is a sphingosine-1-phosphate (SIP) receptor prodrug agonist, similar in action to the approved MS drug fingolimod, but with improved receptor subtype selectivity [3].
Selective SIP1 receptor agonists are being investigated for immunomodulatory/immunosuppresant action in MS and other autoimmune conditions [2]. |
|
Classification | |
Compound class | Synthetic organic |
Is prodrug? | Yes |
Active form | amiselimod phosphate |
IUPAC Name |
2-amino-2-[2-[4-heptoxy-3-(trifluoromethyl)phenyl]ethyl]propane-1,3-diol |
International Nonproprietary Names | |
INN number | INN |
10021 | amiselimod |
Synonyms |
Example 1 [US20090137530] | MT-1303 | MT1303 |
Database Links | |
CAS Registry No. | 942399-20-4 (source: WHO INN record) |
GtoPdb PubChem SID | 318164838 |
PubChem CID | 16129483 |
Search Google for chemical match using the InChIKey | JVCPIJKPAKAIIP-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | JVCPIJKPAKAIIP |
Search PubMed clinical trials | amiselimod |
Search PubMed titles | amiselimod |
Search PubMed titles/abstracts | amiselimod |
UniChem Compound Search for chemical match using the InChIKey | JVCPIJKPAKAIIP-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | JVCPIJKPAKAIIP-UHFFFAOYSA-N |